3 Min.

[Official Trailer] Special Episode (PART 4) - Conversation with KOL Hepatologists and Pharma Thought Leaders in NASH Dialogues on AI Digital Pathology

    • Neues aus der Technik

Dialogues on AI Digital Pathology is releasing Part 4 of its Special Episode real soon!

Listen to this trailer for a snippet of Part 4 with our guests, KOL hepatologists and Pharma Thought Leaders in NASH, as they continue their discussions on AI Digital Pathology (AI-DP), and the application and future of AI-DP in clinical practice, liver research, and drug development. 



Guests

Prof. Stephen Harrison, Medical Director, Pinnacle Clinical Research

Prof. Vlad Ratziu, Professor of Hepatology, Sorbonne University and Pitié-Salpêtrière Hospital

Dr. Judith Ertle, Senior Clinical Program Lead NASH, Boehringer Ingelheim

Dr. Karin Conde-Knape, ‎Senior Vice President Global Drug Discovery, Novo Nordisk



Absent with Apologies

Ms. Kitty Yale, EVP and Chief Development Officer, Akero Therapeutics



Moderator

Dr. Nikolai Naoumov, Senior Adviser, Clinical Research and Drug Development in Liver Diseases, Novartis



Do remember to Subscribe to our Podcast to receive updates on new episodes!

Dialogues on AI Digital Pathology is releasing Part 4 of its Special Episode real soon!

Listen to this trailer for a snippet of Part 4 with our guests, KOL hepatologists and Pharma Thought Leaders in NASH, as they continue their discussions on AI Digital Pathology (AI-DP), and the application and future of AI-DP in clinical practice, liver research, and drug development. 



Guests

Prof. Stephen Harrison, Medical Director, Pinnacle Clinical Research

Prof. Vlad Ratziu, Professor of Hepatology, Sorbonne University and Pitié-Salpêtrière Hospital

Dr. Judith Ertle, Senior Clinical Program Lead NASH, Boehringer Ingelheim

Dr. Karin Conde-Knape, ‎Senior Vice President Global Drug Discovery, Novo Nordisk



Absent with Apologies

Ms. Kitty Yale, EVP and Chief Development Officer, Akero Therapeutics



Moderator

Dr. Nikolai Naoumov, Senior Adviser, Clinical Research and Drug Development in Liver Diseases, Novartis



Do remember to Subscribe to our Podcast to receive updates on new episodes!

3 Min.